NeuroPace (NASDAQ:NPCE) raised its 2026 revenue outlook after reporting first-quarter results that management said reflected continued demand for its RNS System and improving commercial execution ...

In the quarter, LivaNova delivered 10% organic revenue growth versus the prior year, driven by continued momentum in our cardiopulmonary business and solid neuromodulation performance across all ...

NeuroPace, Inc. , a medical device company focused on transforming the lives of people living with drug resistant epilepsy, today announced a major milestone in its clinical evidence program with the ...

Xenon Pharmaceuticals XENE reported a loss of $1.17 per share in the first quarter of 2026, matching the Zacks Consensus ...

In today's Pharmaceutical Executive Daily, Angelini Pharma announces a $4.1 billion agreement to acquire Catalyst ...

A 1000-women study has found a link between being the good daughter and chronic illness as an adult. Here's what the experts say.

Dear Dr. Roach: My husband suffered a grand mal seizure about six months ago. He was in the hospital for seven days. When he came out of the seizure, he was very combative and experienced memory loss.

Researchers assessed whether semaglutide initiation was associated with risk for adult-onset epilepsy or seizures in adults ...

Reported positive topline data from Phase 3 X-TOLE2 study of azetukalner in FOS in March and anticipate NDA submission in Q3 2026Five additional ...

Most people have memory loss in the minutes before and after a generalized seizure, and they are often confused for a period ...